Hot Flash Alert
WASHINGTON, DC (October 25, 2012) - The internet is heating up with hormone therapy in the news again, but don’t form any conclusions until the best and the brightest in this field meet on November 30, 2012 in Washington, D.C.
Why? Many of the scientists do not agree with some of the recent findings and the inconsistencies among reports. Does menopausal hormone replacement therapy help reduce the risk of death from cardiovascular disease, without an increased risk of developing cancer, or not? If hormone therapy does reduce mortality, why is the consensus still that the risks outweigh the benefits? Do the risks and benefits depend on when the hormone therapy is initiated? Are the conclusions more about politics than science?
Almost a year ago the Society for Women’s Health Research (SWHR) decided to convene an international group of preeminent researchers to examine, in detail, the reports released this fall and produce a summary of the evidence and directions for future research. The roundtable is a closed meeting, but media events will follow and a summary report will be produced.
We have waited 10 years since the WHI; let’s wait one more month to learn from their discussions and better understand the findings of the various reports.
The following researchers will attend:
- Pauline Maki, PhD, Professor and Director of Women's Mental Health Research, University of Illinois
- John Morrison, PhD, Professor, Geriatrics and Adult Development, Mount Sinai
- Victor Henderson, MD, Professor, Health Research & Policy - Epidemiology; Neurology, Stanford University
- Sanjay Asthana, MD, Director, Geriatric Research, Education and Clinical Center (GRECC), University of Wisconsin, Madison
- JoAnn Manson, MD, MPH, Professor, Department of Epidemiology, Harvard Medical School
- Howard Hodis, MD, Director, Atherosclerosis Research Unit, University of Southern California
- Louise Schierbeck, MD, Endocrinologist, Hvidovre Hospital, Denmark
- Samuel Shapiro, Professor, Department of Public Health and Family Medicine, University of Cape Town Medical School
- John Stevenson, MB BS, FRCP, FESC, MFSEM, Consultant Physician and Endocrinologist, Imperial College, London
- Richard Karas, MD, PhD, Co-Director, Women's Heart Center, Tufts University School of Medicine
- S. Mitchell Harman, MD, PhD, Director and President, Kronos Longevity Research Institute
- Wulf Utian, MD, PhD, DSc(Med), Professor Emeritus of Reproductive Biology, Case Western Reserve University
- Nancy Woods, PhD, RN, FAAN, Professor, Biobehavioral Nursing and Health Systems, University of Washington
- Shelley Salpeter, MD, Clinical Professor of Medicine, Stanford University
- J. Chris Gallagher, MD, Director, Bone Metabolism Unit, Creighton University
- Bob Lindsay, MD, PhD, Chief, Internal Medicine, Helen Hayes Hospital, Columbia University
- Jane Cauley, DrPH, Professor, Department of Epidemiology, University of Pittsburgh
- Roger Lobo, MD, Chairman of Obstetrics and Gynecology, Columbia University